Gatifloxacin-Q-Acid CAS 112811-72-0 Purity >98.0% (HPLC)
Shanghai Ruifu Chemical Co., Ltd. is the leading manufacturer of Gatifloxacin-Q-Acid (CAS: 112811-72-0) with high quality. Ruifu Chemical can provide worldwide delivery, competitive price, excellent service, small and bulk quantities available. Purchase Gatifloxacin-Q-Acid, Please contact: alvin@ruifuchem.com
| Chemical Name | Gatifloxacin-Q-Acid |
| Synonyms | 1-Cyclopropyl-6,7-Difluoro-8-Methoxy-4-Oxo-3-Quinolinecarboxylic Acid; 1-Cyclopropyl-6,7-Difluoro-8-Methoxy-4-Oxo-1,4-Dihydroquinoline-3-Carboxylic Acid; 1-Cyclopropyl-6,7-Difluoro-1,4 Dihydro-8-Methoxy-4-Oxo-3-Quinoline Carboxylic Acid; Ciprofloxacin Difluoro 8-Methoxy Impurity; Moxifloxacin Difluoro Methoxy Acid Impurity; USP Gatifloxacin Related Compound C; Difluoro Methoxy Gatifloxacin |
| Stock Status | In Stock, Commercial Production |
| CAS Number | 112811-72-0 |
| Molecular Formula | C14H11F2NO4 |
| Molecular Weight | 295.24 g/mol |
| Melting Point | 192.0~194.0℃ |
| Density | 1.581±0.06 g/cm3 |
| COA & MSDS | Available |
| Sample | Available |
| Origin | Shanghai, China |
| Brand | Ruifu Chemical |
| Items | Specifications | Results |
| Appearance | Off-White to Light Yellow Powder |
Complies |
| Loss on Drying | <0.50% | 0.30% |
| Gatifloxacin Ester | <0.50% | 0.30% |
| Any Other Impurity | <0.30% | 0.19% |
| Purity / Analysis Method | >98.0% (HPLC) | 99.15% |
| Infrared Spectrum | Consistent with Structure | Complies |
| 1H NMR Spectrum | Consistent with Structure | Complies |
| LCMS | Consistent with Structure | Complies |
| Conclusion | The product has been tested and complies with the given specifications | |
| Application | Intermediate of Gatifloxacin / Moxifloxacin Hydrochloride | |
Package: Bottle, Aluminium foil bag, 25kg/Cardboard Drum, or according to customer's requirement.
Storage Condition: Keep the container tightly closed and store in a cool, dry (2~8℃) and well-ventilated warehouse away from incompatible substances. Protect from light and moisture.
Shipping: Deliver to worldwide by air, by FedEx / DHL Express. Provide fast and reliable delivery.
How to Purchase? Please contact Dr. Alvin Huang: sales@ruifuchem.com or alvin@ruifuchem.com
15 Years Experience? We have more than 15 years of experience in the manufacture and export of a wide range of high quality pharmaceutical intermediates or fine chemicals.
Main Markets? Sell to domestic market, North America, Europe, India, Korea, Japanese, Australia, etc.
Advantages? Superior quality, affordable price, professional services and technical support, fast delivery.
Quality Assurance? Strict quality control system. Professional equipment for analysis include NMR, LC-MS, GC, HPLC, ICP-MS, UV, IR, OR, K.F, ROI, LOD, MP, Clarity, Solubility, Microbial limit test, etc.
Samples? Most products provide free samples for quality evaluation, shipping cost should be paid by customers.
Factory Audit? Factory audit welcome. Please make an appointment in advance.
MOQ? No MOQ. Small order is acceptable.
Delivery Time? If within stock, three days delivery guaranteed.
Transportation? By Express (FedEx, DHL), by Air, by Sea.
Documents? After sales service: COA, MOA, ROS, MSDS, etc. can be provided.
Custom Synthesis? Can provide custom synthesis services to best fit your research needs.
Payment Terms? Proforma invoice will be sent first after confirmation of order, enclosed our bank information. Payment by T/T (Telex Transfer), PayPal, Western Union, etc.
| Hazard Symbols | Xn - Harmful |
| Risk Codes | 22 - Harmful if swallowed |
| Safety Description | 24/25 - Avoid contact with skin and eyes. |
| HS Code | 2933 4900.90 |
| Hazard Class | IRRITANT |
Gatifloxacin-Q-Acid (CAS: 112811-72-0) is an intermediate of Gatifloxacin (CAS: 112811-59-3) / Moxifloxacin Hydrochloride (CAS: 186826-86-8).
Gatifloxacin (brand names Gatiflo, Tequin, and Zymar) is an antibiotic of the fourth-generation fluoroquinolone family, that like other members of that family, inhibits the bacterial enzymes DNA gyrase and topoisomerase IV.
It was patented in 1986 and approved for medical use in 1999. Gatifloxacin belongs to a class of drugs known as quinolone antibiotics and is used to treat acute sinus, lung, or urinary tract infections and sexually transmitted bacterial infection.This drug may be taken orally, in tablet form, or by injection.
Moxifloxacin Hydrochloride is a fluoroquinolone antibiotic developed by Bayer Pharmaceuticals (Germany.) It can be used to treat community-acquired pneumonia caused by Staphylococcus aureus, baccilus, pneumococcus, mucositis Moraxella, and Klebsiella pneumoniae, acute chronic bronchitis attacks, and acute sinusitis. For the treatment of adult bacterial lung infections, paranasal sinus, skin, and abdominal cavity. Also used to treat community-acquired pneumonia, chronic bronchitis, urogenital infection, and acute sinusitis.
The synthesis of novel quinoline derivatives begins with the reaction of the starting material, 1-Cyclopropyl-6,7-Difluoro-8-Methoxy-4-Oxo-1,4-Dihydroquinoline-3-Carboxylic Acid (CAS: 112811-72-0), with a variety of reagents such as alcohols, amines and acids. These reactions produce a range of quinoline derivatives with different functionalities. The compounds produced can then be further modified to generate new compounds with potential therapeutic activities. For example, the reaction of the starting material with an amine can produce a quinolone derivative which can then be subjected to a range of other reactions such as reduction, oxidation or alkylation to produce a range of compounds with different properties. These compounds can then be tested for their potential therapeutic activities.
